|
|
|
Table of Contents
March 4, 2002
Volume 80, Number 9
CENEAR 80 9 p. 3
| COVER STORY |
|
|
MERGER & ACQUISITIONS
With Dow leading the charge, the chemical industry saw $37 billion worth of deals in 2001. |
| BUSINESS |
|
|
BUSINESS CONCENTRATES |
|
|
PHARMACEUTICALS
Genomics advances force Novartis to take a new approach to R&D. |
|
|
P&G CHEMICALS
Bucking the trend, Procter & Gamble stays its course in chemicals. |
|
|
GROWING PAINS
BP Chemicals says its big challenge for the year is integrating assets from its acquisitions and joint ventures. |
|
|
INSIGHTS
Within weeks of the full realization of the Enron mess, calls for reform started, and all will ultimately feel the result. |
| GOVERNMENT & POLICY |
|
|
GOVERNMENT CONCENTRATES |
|
|
SCIENCE POLICY
At the AAAS meeting, presenters focused on issues confronting the global R&D enterprise. |
|
|
R&D BUDGET
Marburger appears at House hearing to explain Administration's huge boost for NIH. |
| BOOKS |
|
|
"MENDELEYEV'S DREAM"
Author succeeds in bringing to life the history of chemistry, with the elements as its focus. |
|
|
|
